![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Manocha Sanjay Feinstein Daniel Kumar Aseem Kumar Anand
Publisher: Informa Healthcare
ISSN: 1354-3784
Source: Expert Opinion on Investigational Drugs, Vol.11, Iss.12, 2002-12, pp. : 1795-1812
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel Therapies for Microvascular Permeability in Sepsis
Current Drug Targets, Vol. 8, Iss. 4, 2007-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Current Topics in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Pharmacoeconomic Implications of New Therapies in Sepsis
By Kelly A. Wood Derek C. Angus
PharmacoEconomics, Vol. 22, Iss. 14, 2004-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Strategies for Novel COPD Therapies
By Barnes P.J.
Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Novel therapies for CMV are emerging
Inpharma, Vol. 1, Iss. 1393, 2003-01 ,pp. :